Program Covers Broad Spectrum of Topics in Thoracic Oncology
Erin JungmeyerThe chairs of WCLC 2023 say this year’s program offers something for everyone, including practice-changing clinical trial data and innovative basic science as well as presentations to address broader needs within the profession. Read more
Make the Most of WCLC 2023: Mobile App Launches August 31
Erin JungmeyerWhether you are attending in-person or virtually, the conference app will help you navigate the meeting and connect with your colleagues from around the globe. Read more
Before you pack your bags, make sure you know everything you will need to get to the 2023 World Conference on Lung Cancer without delay. Read more
As you plan your WCLC 2023 itinerary, don’t miss an important session on your list because you don’t have a ticket. Review the ticketed events schedule and be sure you have any tickets you will need. Read more
Neoadjuvant Immunotherapy in NSCLC: A Window of Opportunity Not to Be Missed
Jamie E. Chaft, MDDr. Jamie Chaft says neoadjuvant chemoimmunotherapy offers thoracic oncologists an opportunity to cure more patients. Read more
Adjuvant IO for Operable NSCLC: Where Does It Fit a Changing Landscape?
Michael Davidson, MD+more
Dr. Mary O’Brien and colleagues say decision making around operable cases is becoming increasingly complex, making a multidisciplinary approach imperative. Read more
Demystifying AI: How Will Artificial Intelligence Alter the Practice of Thoracic Oncology?
Raymond H. Mak, MD+more
In Part 2 of their exploration of artificial intelligence, Dr. Raymond Mak and Fridolin Haugg reflect on the possibilities ahead for the diagnosis and treatment of lung cancer. Read more
Inflammation’s Dark Symphony: Lung Cancer and Depression in Concert
Barbara L. Andersen, PhDDr. Barbara Andersen’s research has shown depression severity is associated with prognostically poor inflammation in patients with non-small cell lung cancer. Read more
IASLC Hot Topic meeting to feature keynote address on resistance to immunotherapy by Dr. Drew Pardoll. Lung Cancer Research Foundation announces appointment of new executive director Aubrey Rhodes. Read more
Demystifying AI: Current Insights on Artificial Intelligence in Thoracic Oncology
Raymond H. Mak, MD+more
Dr. Raymond Mak and Fridolin Haugg delve into the artificial intelligence discussion with an overview of AI basics and a look at how AI is already influencing the lung cancer field. Read more